{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T23:28:11Z","timestamp":1790810891049,"version":"4.1.0"},"reference-count":152,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1016\/j.antiviral.2020.104780","type":"journal-article","created":{"date-parts":[[2020,3,27]],"date-time":"2020-03-27T11:07:23Z","timestamp":1585307243000},"page":"104780","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":79,"special_numbering":"C","title":["Put a cork in it: Plugging the M2 viral ion channel to sink influenza"],"prefix":"10.1016","volume":"178","author":[{"given":"Pouria H.","family":"Jalily","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maggie C.","family":"Duncan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Fedida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian","family":"Tietjen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.antiviral.2020.104780_bib1","doi-asserted-by":"crossref","first-page":"15075","DOI":"10.1073\/pnas.1007071107","article-title":"Structure and mechanism of proton transport through the transmembrane tetrameric M2 protein bundle of the influenza A virus","volume":"107","author":"Acharya","year":"2010","journal-title":"Proc. Natl. Acad. Sci. Unit. States Am."},{"key":"10.1016\/j.antiviral.2020.104780_bib2","doi-asserted-by":"crossref","first-page":"23134","DOI":"10.1074\/jbc.271.38.23134","article-title":"Membrane permeabilization by poliovirus proteins 2B and 2BC","volume":"271","author":"Aldabe","year":"1996","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.antiviral.2020.104780_bib3","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1021\/jm00288a019","article-title":"Antiviral agents. 2. Structure-activity relations of compounds related to 1-adamantanamine","volume":"14","author":"Aldrich","year":"1971","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.antiviral.2020.104780_bib4","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1128\/JVI.03253-14","article-title":"Influenza virus M2 protein ion channel activity helps to maintain pandemic 2009 H1N1 virus hemagglutinin fusion competence during transport to the cell surface","volume":"89","author":"Alvarado-Facundo","year":"2015","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2020.104780_bib5","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1021\/bi901799k","article-title":"Functional studies and modeling of pore-lining residue mutants of the influenza A virus M2 ion channel","volume":"49","author":"Balannik","year":"2010","journal-title":"Biochemistry"},{"key":"10.1016\/j.antiviral.2020.104780_bib6","doi-asserted-by":"crossref","first-page":"11872","DOI":"10.1021\/bi9014488","article-title":"Design and pharmacological characterization of inhibitors of amantadine-resistant mutants of the M2 ion channel of influenza A virus","volume":"48","author":"Balannik","year":"2009","journal-title":"Biochemistry"},{"key":"10.1016\/j.antiviral.2020.104780_bib7","series-title":"Screening for Chemical Inhibitors of Heterologous Proteins Expressed in Yeast Using a Simple Growth-Restoration Assay","first-page":"125","author":"Balgi","year":"2009"},{"key":"10.1016\/j.antiviral.2020.104780_bib8","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0055271","article-title":"Inhibitors of the influenza A virus M2 proton channel discovered using a high-throughput yeast growth restoration assay","volume":"8","author":"Balgi","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.antiviral.2020.104780_bib9","doi-asserted-by":"crossref","first-page":"3727","DOI":"10.1021\/acs.jmedchem.6b01758","article-title":"Slow but steady wins the race: dissimilarities among new dual inhibitors of the wild-type and the V27A mutant M2 channels of influenza A virus","volume":"60","author":"Barniol-Xicota","year":"2017","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.antiviral.2020.104780_bib10","doi-asserted-by":"crossref","first-page":"17789","DOI":"10.1074\/jbc.M202018200","article-title":"Modification of late membrane permeability in avian reovirus-infected cells: viroporin activity of the S1-encoded nonstructural p10 protein","volume":"277","author":"Bodel\u00f3n","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.antiviral.2020.104780_bib11","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1016\/S0140-6736(05)67338-2","article-title":"Incidence of adamantane resistance among influenza A (H3N2) viruses isolated worldwide from 1994 to 2005: a cause for concern","volume":"366","author":"Bright","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.antiviral.2020.104780_bib12","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1001\/jama.295.8.joc60020","article-title":"Adamantane resistance among influenza A viruses isolated early during the 2005-2006 influenza season in the United States","volume":"295","author":"Bright","year":"2006","journal-title":"J. Am. Med. Assoc."},{"key":"10.1016\/j.antiviral.2020.104780_bib13","doi-asserted-by":"crossref","first-page":"8391","DOI":"10.1128\/jvi.70.12.8391-8401.1996","article-title":"Effect of M1 protein and low pH on nuclear transport of influenza virus ribonucleoproteins","volume":"70","author":"Bui","year":"1996","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2020.104780_bib14","doi-asserted-by":"crossref","first-page":"11572","DOI":"10.1021\/ja202051n","article-title":"Membrane-dependent effects of a cytoplasmic helix on the structure and drug binding of the influenza virus M2 protein","volume":"133","author":"Cady","year":"2011","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.antiviral.2020.104780_bib15","doi-asserted-by":"crossref","first-page":"7356","DOI":"10.1021\/bi9008837","article-title":"Structure and function of the influenza A M2 proton channel","volume":"48","author":"Cady","year":"2009","journal-title":"Biochemistry"},{"key":"10.1016\/j.antiviral.2020.104780_bib16","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1016\/j.jmb.2008.11.022","article-title":"Structure of amantadine-bound M2 transmembrane peptide of influenza A in lipid bilayers from magic-angle-spinning solid-state NMR: the role of Ser31 in amantadine binding","volume":"385","author":"Cady","year":"2009","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.antiviral.2020.104780_bib17","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1038\/nature08722","article-title":"Structure of the amantadine binding site of influenza M2 proton channels in lipid bilayers","volume":"463","author":"Cady","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.antiviral.2020.104780_bib18","doi-asserted-by":"crossref","first-page":"4274","DOI":"10.1021\/ja102581n","article-title":"Specific binding of adamantane drugs and direction of their polar amines in the pore of the influenza M2 transmembrane domain in lipid bilayers and dodecylphosphocholine micelles determined by NMR spectroscopy","volume":"133","author":"Cady","year":"2011","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.antiviral.2020.104780_bib19","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.sbi.2008.07.001","article-title":"Overcoming the challenges of membrane protein crystallography","volume":"18","author":"Carpenter","year":"2008","journal-title":"Curr. Opin. Struct. Biol."},{"key":"10.1016\/j.antiviral.2020.104780_bib20","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.02325-17","article-title":"Role of severe acute respiratory syndrome coronavirus viroporins E, 3a, and 8a in replication and pathogenesis","volume":"9","author":"Casta\u00f1o-Rodriguez","year":"2018","journal-title":"MBio"},{"key":"10.1016\/j.antiviral.2020.104780_bib21","series-title":"Estimated Influenza Illnesses, Medical Visits, Hospitalizations, and Deaths in the United States \u2014 2017\u20132018 Influenza Season","year":"2018"},{"key":"10.1016\/j.antiviral.2020.104780_bib22","doi-asserted-by":"crossref","first-page":"10059","DOI":"10.1128\/JVI.01184-08","article-title":"The influenza virus M2 protein cytoplasmic tail interacts with the M1 protein and influences virus assembly at the site of virus budding","volume":"82","author":"Chen","year":"2008","journal-title":"J. Virol."},{"issue":"Pt 2","key":"10.1016\/j.antiviral.2020.104780_bib23","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1113\/jphysiol.1996.sp021495","article-title":"Selective proton permeability and pH regulation of the influenza virus M2 channel expressed in mouse erythroleukaemia cells","volume":"494","author":"Chizhmakov","year":"1996","journal-title":"J. Physiol."},{"key":"10.1016\/j.antiviral.2020.104780_bib24","doi-asserted-by":"crossref","first-page":"2846","DOI":"10.1016\/j.bpj.2009.09.004","article-title":"Binding hot spots and amantadine orientation in the influenza A virus M2 proton channel","volume":"97","author":"Chuang","year":"2009","journal-title":"Biophys. J."},{"key":"10.1016\/j.antiviral.2020.104780_bib25","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/0042-6822(92)90730-D","article-title":"Evidence that the amantadine-induced, M2-mediated conversion of influenza A virus hemagglutinin to the low pH conformation occurs in an acidic trans Golgi compartment","volume":"188","author":"Ciampor","year":"1992","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2020.104780_bib26","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.coviro.2012.01.005","article-title":"M2 protein from Influenza A: from multiple structures to biophysical and functional insights","volume":"2","author":"Cross","year":"2012","journal-title":"Curr. Opin. Virol."},{"key":"10.1016\/j.antiviral.2020.104780_bib27","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1038\/nsmb.1779","article-title":"Structures of influenza A proteins and insights into antiviral drug targets","volume":"17","author":"Das","year":"2010","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.antiviral.2020.104780_bib28","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1126\/science.144.3620.862","article-title":"Antiviral activity of 1-adamantanamine (amantadine)","volume":"144","author":"Davies","year":"1964","journal-title":"Science (80)"},{"key":"10.1016\/j.antiviral.2020.104780_bib29","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1086\/518936","article-title":"Surveillance of resistance to adamantanes among influenza A(H3N2) and A(H1N1) viruses isolated worldwide","volume":"196","author":"Deyde","year":"2007","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2020.104780_bib30","article-title":"Adamantane-resistant influenza A viruses in the world (1902\u20132013): frequency and distribution of M2 gene mutations","volume":"10","author":"Dong","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.antiviral.2020.104780_bib31","author":"Dong"},{"key":"10.1016\/j.antiviral.2020.104780_bib32","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1021\/acsmedchemlett.6b00311","article-title":"Affinity of rimantadine enantiomers against influenza A\/M2 protein revisited","volume":"8","author":"Drakopoulos","year":"2017","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.antiviral.2020.104780_bib33","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1016\/j.drudis.2012.06.002","article-title":"Recent progress in structure-based anti-influenza drug design","volume":"17","author":"Du","year":"2012","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.antiviral.2020.104780_bib34","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/0042-6822(92)91239-Q","article-title":"The transmembrane domain of influenza A M2 protein forms amantadine-sensitive proton channels in planar lipid bilayers","volume":"190","author":"Duff","year":"1992","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2020.104780_bib35","doi-asserted-by":"crossref","first-page":"2646","DOI":"10.1021\/jm101334y","article-title":"Exploring the size limit of templates for inhibitors of the M2 ion channel of influenza A virus","volume":"54","author":"Duque","year":"2011","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.antiviral.2020.104780_bib36","series-title":"Investigation of a Recent Rise of Dual Amantadine-Resistance Mutations in the Influenza A M2 Sequence","author":"Durrant","year":"2014"},{"key":"10.1016\/j.antiviral.2020.104780_bib37","first-page":"1","article-title":"Antiviral agents for the treatment and chemoprophylaxis of influenza --- recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"60","author":"Fiore","year":"2011","journal-title":"MMWR Recomm. Rep. (Morb. Mortal. Wkly. Rep.)"},{"key":"10.1016\/j.antiviral.2020.104780_bib38","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.bbamem.2010.05.014","article-title":"Viral channel forming proteins - modeling the target","volume":"1808","author":"Fischer","year":"2011","journal-title":"Biochim. Biophys. Acta Biomembr."},{"key":"10.1016\/j.antiviral.2020.104780_bib39","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/1743-422X-6-67","article-title":"Evolution of the M gene of the influenza A virus in different host species: large-scale sequence analysis","volume":"6","author":"Furuse","year":"2009","journal-title":"Virol. J."},{"key":"10.1016\/j.antiviral.2020.104780_bib40","doi-asserted-by":"crossref","first-page":"4457","DOI":"10.1128\/AAC.00650-09","article-title":"Large-scale sequence analysis of M gene of influenza A viruses from different species: mechanisms for emergence and spread of amantadine resistance","volume":"53","author":"Furuse","year":"2009","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2020.104780_bib41","doi-asserted-by":"crossref","first-page":"24671","DOI":"10.1074\/jbc.M111.332791","article-title":"The small hydrophobic protein of the human respiratory syncytial virus forms pentameric ion channels","volume":"287","author":"Gan","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.antiviral.2020.104780_bib42","doi-asserted-by":"crossref","first-page":"5474","DOI":"10.1074\/jbc.274.9.5474","article-title":"Cu(II) inhibition of the proton translocation machinery of the influenza a virus M2 protein","volume":"274","author":"Gandhi","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.antiviral.2020.104780_bib43","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1016\/j.drudis.2012.05.002","article-title":"Viral targets of acylguanidines","volume":"17","author":"Gazina","year":"2012","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.antiviral.2020.104780_bib44","series-title":"Resistance-Mutation (N31) Effects on Drug Orientation and Channel Hydration in Amantadine-Bound Influenza A M2","author":"Gleed","year":"2015"},{"key":"10.1016\/j.antiviral.2020.104780_bib45","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.antiviral.2017.10.009","article-title":"Divalent copper complexes as influenza A M2 inhibitors","volume":"147","author":"Gordon","year":"2017","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2020.104780_bib46","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/0042-6822(92)90229-I","article-title":"Influence of amantadine resistance mutations on the pH regulatory function of the M2 protein of influenza A viruses","volume":"191","author":"Grambas","year":"1992","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2020.104780_bib47","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.tips.2013.08.003","article-title":"Structural and energetic analysis of drug inhibition of the influenza A M2 proton channel","volume":"34","author":"Gu","year":"2013","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.antiviral.2020.104780_bib48","doi-asserted-by":"crossref","first-page":"10817","DOI":"10.1021\/ja1114198","article-title":"Free energy calculations on the two drug binding sites in the M2 proton channel","volume":"133","author":"Gu","year":"2011","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.antiviral.2020.104780_bib49","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1021\/bi00052a014","article-title":"Effects of exposure to low pH on the lateral mobility of influenza hemagglutinin expressed at the cell surface: correlation between mobility inhibition and inactivation","volume":"32","author":"Gutman","year":"1993","journal-title":"Biochemistry"},{"key":"10.1016\/j.antiviral.2020.104780_bib50","doi-asserted-by":"crossref","DOI":"10.1093\/infdis\/jiq012","article-title":"Emerging influenza antiviral resistance threats","author":"Hayden","year":"2011","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2020.104780_bib51","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1128\/jvi.68.3.1551-1563.1994","article-title":"Influenza A virus M2 ion channel protein: a structure-function analysis","volume":"68","author":"Holsinger","year":"1994","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2020.104780_bib52","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1128\/jvi.69.2.1219-1225.1995","article-title":"Analysis of the posttranslational modifications of the influenza virus M2 protein","volume":"69","author":"Holsinger","year":"1995","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2020.104780_bib53","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1002\/pro.2158","article-title":"Structural basis for proton conduction and inhibition by the influenza M2 protein","volume":"21","author":"Hong","year":"2012","journal-title":"Protein Sci."},{"key":"10.1016\/j.antiviral.2020.104780_bib54","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1126\/science.1191714","article-title":"Mechanisms of proton conduction and gating in influenza M2 proton channels from solid-state NMR","volume":"330","author":"Hu","year":"2010","journal-title":"Science (80)"},{"key":"10.1016\/j.antiviral.2020.104780_bib55","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1021\/acsmedchemlett.8b00336","article-title":"Structure-Property relationship studies of influenza A virus AM2-S31N proton channel blockers","volume":"9","author":"Hu","year":"2018","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.antiviral.2020.104780_bib56","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.antiviral.2017.01.006","article-title":"An M2-V27A channel blocker demonstrates potent in vitro and in vivo antiviral activities against amantadine-sensitive and -resistant influenza A viruses","volume":"140","author":"Hu","year":"2017","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2020.104780_bib57","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.ejmech.2017.04.038","article-title":"Design and expeditious synthesis of organosilanes as potent antivirals targeting multidrug-resistant influenza A viruses","volume":"135","author":"Hu","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.antiviral.2020.104780_bib152","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.coviro.2014.04.009","article-title":"The epidemiology and spread of drug resistant human influenza viruses","volume":"8","author":"Hurt","year":"2014","journal-title":"Curr. Opin. Virol."},{"key":"10.1016\/j.antiviral.2020.104780_bib58","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1124\/mol.115.102731","article-title":"Mechanisms of action of novel influenza A\/M2 viroporin inhibitors derived from hexamethylene amiloride","volume":"90","author":"Jalily","year":"2016","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.antiviral.2020.104780_bib59","first-page":"1441","article-title":"Salinomycin inhibits influenza virus infection by disrupting endosomal acidification and viral matrix protein 2 function salinomycin inhibits influenza virus infection by disrupting endosomal acidification and viral matrix protein 2 function VACCINES AND","volume":"92","author":"Jang","year":"2018","journal-title":"jvi.asm.org 1 J. Virol."},{"key":"10.1016\/j.antiviral.2020.104780_bib60","doi-asserted-by":"crossref","first-page":"10967","DOI":"10.1073\/pnas.0804958105","article-title":"Functional studies indicate amantadine binds to the pore of the influenza A virus M2 proton-selective ion channel","volume":"105","author":"Jing","year":"2008","journal-title":"Proc. Natl. Acad. Sci. Unit. States Am."},{"key":"10.1016\/j.antiviral.2020.104780_bib61","series-title":"Bovine Ephemeral Fever Rhabdovirus 1 Protein Has Viroporin-like Properties and Binds Importin 1 and Importin 7","author":"Joubert","year":"2014"},{"key":"10.1016\/j.antiviral.2020.104780_bib62","doi-asserted-by":"crossref","first-page":"12162","DOI":"10.1128\/JVI.76.23.12162-12172.2002","article-title":"The human papillomavirus type 16 E5 protein impairs TRAIL- and FasL-mediated apoptosis in HaCaT cells by different mechanisms","volume":"76","author":"Kabsch","year":"2002","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2020.104780_bib63","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0199227","article-title":"Influenza D virus M2 protein exhibits ion channel activity in Xenopus laevis oocytes","volume":"13","author":"Kesinger","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.antiviral.2020.104780_bib64","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1001\/archinte.160.10.1485","article-title":"Comparison of central nervous system Adverse effects of amantadine and rimantadine used as sequential prophylaxis of influenza A in elderly nursing home patients","volume":"160","author":"Keyser","year":"2000","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.antiviral.2020.104780_bib65","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.bbamem.2010.03.025","article-title":"Computational study of drug binding to the membrane-bound tetrameric M2 peptide bundle from influenza A virus","volume":"1808","author":"Khurana","year":"2011","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.antiviral.2020.104780_bib66","article-title":"Spotting differences in molecular dynamic simulations of influenza A M2 protein-ligand complexes by varying M2 construct, lipid bilayer and force field","author":"Kolokouris","year":"2019","journal-title":"ChemRxiv"},{"key":"10.1016\/j.antiviral.2020.104780_bib67","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1006\/jmbi.1999.3322","article-title":"Helix tilt of the M2 transmembrane peptide from influenza A virus: an intrinsic property","volume":"295","author":"Kovacs","year":"2000","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.antiviral.2020.104780_bib68","series-title":"Orthomyxoviridae: the Viruses and Their Replication","author":"Lamb","year":"2001"},{"key":"10.1016\/j.antiviral.2020.104780_bib69","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/0042-6822(81)90317-2","article-title":"Identification of a second protein (M2) encoded by RNA segment 7 of influenza virus","volume":"112","author":"Lamb","year":"1981","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2020.104780_bib70","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1016\/0042-6822(81)90319-6","article-title":"Conservation of the influenza virus membrane protein (M1) amino acid sequence and an open reading frame of RNA segment 7 encoding a second protein (M2) in H1N1 and H3N2 strains","volume":"112","author":"Lamb","year":"1981","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2020.104780_bib71","doi-asserted-by":"crossref","first-page":"4170","DOI":"10.1073\/pnas.78.7.4170","article-title":"Sequences of mRNAs derived from genome RNA segment 7 of influenza virus: colinear and interrupted mRNAs code for overlapping proteins","volume":"78","author":"Lamb","year":"1981","journal-title":"Proc. Natl. Acad. Sci. Unit. States Am."},{"key":"10.1016\/j.antiviral.2020.104780_bib72","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/0092-8674(85)90211-9","article-title":"Influenza virus M2 protein is an integral membrane protein expressed on the infected-cell surface","volume":"40","author":"Lamb","year":"1985","journal-title":"Cell"},{"key":"10.1016\/j.antiviral.2020.104780_bib73","doi-asserted-by":"crossref","first-page":"15409","DOI":"10.1073\/pnas.1009997107","article-title":"Proton and cation transport activity of the M2 proton channel from influenza A virus","volume":"107","author":"Leiding","year":"2010","journal-title":"Proc. Natl. Acad. Sci. Unit. States Am."},{"key":"10.1016\/j.antiviral.2020.104780_bib74","series-title":"Expeditious Lead Optimization of Isoxazole-Containing Influenza A Virus M2-S31n Inhibitors Using the Suzuki\u2212Miyaura Cross-Coupling Reaction","author":"Li","year":"2017"},{"key":"10.1016\/j.antiviral.2020.104780_bib75","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1021\/acs.jmedchem.5b01910","article-title":"Discovery of highly potent inhibitors targeting the predominant drug-resistant S31N mutant of the influenza A virus M2 proton channel","volume":"59","author":"Li","year":"2016","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.antiviral.2020.104780_bib76","first-page":"726","article-title":"Discovery of potent antivirals against amantadine-resistant influenza A viruses by targeting the M2-S31N proton channel Graphical abstract Keywords Influenza A virus; M2 proton channel","volume":"2","author":"Li","year":"2016","journal-title":"M2-S31N inhibitor HHS Public Access"},{"key":"10.1016\/j.antiviral.2020.104780_bib77","series-title":"pH-Controlled Two-step Uncoating of Influenza Virus","author":"Li","year":"2014"},{"key":"10.1016\/j.antiviral.2020.104780_bib151","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1016\/j.str.2013.08.029","article-title":"Asp44 stabilizes the Trp41 gate of the M2 proteon channel of influenza A virus","volume":"21","author":"Ma","year":"2013","journal-title":"Structure"},{"key":"10.1016\/j.antiviral.2020.104780_bib78","doi-asserted-by":"crossref","first-page":"12283","DOI":"10.1073\/pnas.0905726106","article-title":"Identification of the functional core of the influenza A virus A\/M2 proton-selective ion channel","volume":"106","author":"Ma","year":"2009","journal-title":"Proc. Natl. Acad. Sci. Unit. States Am."},{"key":"10.1016\/j.antiviral.2020.104780_bib79","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1124\/mol.116.105346","article-title":"Pharmacological characterization of the spectrum of antiviral activity and genetic barrier to drug resistance of M2-S31N channel blockers","volume":"90","author":"Ma","year":"2016","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.antiviral.2020.104780_bib80","doi-asserted-by":"crossref","first-page":"4461","DOI":"10.3390\/v7082826","article-title":"Structural and functional properties of the hepatitis C virus p7 viroporin","volume":"7","author":"Madan","year":"2015","journal-title":"Viruses"},{"key":"10.1016\/j.antiviral.2020.104780_bib81","doi-asserted-by":"crossref","DOI":"10.1016\/0092-8674(91)90576-K","article-title":"Nuclear transport of influenza virus ribonucleoproteins: the viral matrix protein (ml) promotes export and inhibits import","author":"Martin","year":"1991","journal-title":"Cell"},{"key":"10.1016\/j.antiviral.2020.104780_bib82","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S1534-5807(03)00190-4","article-title":"Influenza B virus BM2 protein has ion channel activity that conducts protons across membranes","volume":"5","author":"Mould","year":"2003","journal-title":"Dev. Cell"},{"key":"10.1016\/j.antiviral.2020.104780_bib83","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1124\/mol.119.116640","article-title":"The L46P mutant confers a novel allosteric mechanism of resistance toward the influenza A virus M2 S31N proton channel blockers","volume":"96","author":"Musharrafieh","year":"2019","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.antiviral.2020.104780_bib84","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.antiviral.2018.03.002","article-title":"Profiling the in vitro drug-resistance mechanism of influenza A viruses towards the AM2-S31N proton channel blockers","volume":"153","author":"Musharrafieh","year":"2018","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2020.104780_bib85","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.virol.2009.03.026","article-title":"The origin and global emergence of adamantane resistant A\/H3N2 influenza viruses","volume":"388","author":"Nelson","year":"2009","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2020.104780_bib86","doi-asserted-by":"crossref","first-page":"3552","DOI":"10.3390\/v7072786","article-title":"Relevance of viroporin ion channel activity on viral replication and pathogenesis","volume":"7","author":"Nieto-Torres","year":"2015","journal-title":"Viruses"},{"key":"10.1016\/j.antiviral.2020.104780_bib153","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1038\/nrmicro2820","article-title":"Viroporins: Structure and biological functions","volume":"10","author":"Nieva","year":"2012","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.antiviral.2020.104780_bib87","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1016\/j.bbamem.2013.09.004","article-title":"The minimalist architectures of viroporins and their therapeutic implications","volume":"1838","author":"Ouyang","year":"2014","journal-title":"Biochim. Biophys. Acta Biomembr."},{"key":"10.1016\/j.antiviral.2020.104780_bib88","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1016\/S0006-3495(02)75239-9","article-title":"Effect of the environment on the protein dynamical transition: a neutron scattering study","volume":"83","author":"Paciaroni","year":"2002","journal-title":"Biophys. J."},{"key":"10.1016\/j.antiviral.2020.104780_bib90","first-page":"13233","article-title":"Influenza C virus CM2 integral membrane glycoprotein is produced from a polypeptide precursor by cleavage of an internal signal sequence","volume":"95","author":"Pekosz","year":"1998","journal-title":"Microbiology"},{"key":"10.1016\/j.antiviral.2020.104780_bib91","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1000511","article-title":"Structure and inhibition of the SARS coronavirus envelope protein ion channel","volume":"5","author":"Pervushin","year":"2009","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.antiviral.2020.104780_bib93","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.bbrc.2010.09.008","article-title":"Solution NMR structure of the V27A drug resistant mutant of influenza A M2 channel","volume":"401","author":"Pielak","year":"2010","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.antiviral.2020.104780_bib94","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1016\/j.str.2011.09.003","article-title":"Structural investigation of rimantadine inhibition of the AM2-BM2 chimera channel of influenza viruses","volume":"19","author":"Pielak","year":"2011","journal-title":"Structure"},{"key":"10.1016\/j.antiviral.2020.104780_bib95","doi-asserted-by":"crossref","first-page":"7379","DOI":"10.1073\/pnas.0902548106","article-title":"Mechanism of drug inhibition and drug resistance of influenza A M2 channel","volume":"106","author":"Pielak","year":"2009","journal-title":"Proc. Natl. Acad. Sci. Unit. States Am."},{"key":"10.1016\/j.antiviral.2020.104780_bib96","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/0092-8674(92)90452-I","article-title":"Influenza virus M2 protein has ion channel activity","volume":"69","author":"Pinto","year":"1992","journal-title":"Cell"},{"key":"10.1016\/j.antiviral.2020.104780_bib97","doi-asserted-by":"crossref","first-page":"8997","DOI":"10.1074\/jbc.R500020200","article-title":"The M2 proton channels of influenza A and B viruses","volume":"281","author":"Pinto","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.antiviral.2020.104780_bib98","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0014-5793(03)01453-4","article-title":"Cation-selective ion channels formed by p7 of hepatitis C virus are blocked by hexamethylene amiloride","volume":"557","author":"Premkumar","year":"2004","journal-title":"FEBS Lett."},{"key":"10.1016\/j.antiviral.2020.104780_bib99","series-title":"Automated Electrophysiology Assays, Assay Guidance Manual","author":"Priest","year":"2017"},{"key":"10.1016\/j.antiviral.2020.104780_bib100","doi-asserted-by":"crossref","first-page":"67","DOI":"10.3389\/fcimb.2019.00067","article-title":"Virtual screen for repurposing of drugs for candidate influenza a M2 ion-channel inhibitors","volume":"9","author":"Radosevic","year":"2019","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.antiviral.2020.104780_bib154","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.jcv.2011.05.019","article-title":"Emerging oseltamivir resistance in seasonal and pandemic influenza A\/H1N1","volume":"52","author":"Renaud","year":"2011","journal-title":"J. Clin. Virol."},{"key":"10.1016\/j.antiviral.2020.104780_bib101","doi-asserted-by":"crossref","first-page":"5738","DOI":"10.1021\/jm5005804","article-title":"Easily accessible polycyclic amines that inhibit the wild-type and amantadine-resistant mutants of the M2 channel of influenza A virus","volume":"57","author":"Rey-Carrizo","year":"2014","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.antiviral.2020.104780_bib102","doi-asserted-by":"crossref","first-page":"9265","DOI":"10.1021\/jm401340p","article-title":"3-azatetracyclo[5.2.1.15,8.01,5]undecane Derivatives: from wild-type inhibitors of the M2 ion channel of influenza A virus to derivatives with potent activity against the V27A mutant","volume":"56","author":"Rey-Carrizo","year":"2013","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.antiviral.2020.104780_bib103","doi-asserted-by":"crossref","DOI":"10.1093\/cid\/ciz075","article-title":"Effects of influenza vaccination in the United States during the 2017\u20132018 influenza season","author":"Rolfes","year":"2019","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.antiviral.2020.104780_bib104","doi-asserted-by":"crossref","first-page":"13866","DOI":"10.1073\/pnas.1002051107","article-title":"Coexistence of two adamantane binding sites in the influenza A M2 ion channel","volume":"107","author":"Rosenberg","year":"2010","journal-title":"Proc. Natl. Acad. Sci. Unit. States Am."},{"key":"10.1016\/j.antiviral.2020.104780_bib105","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.virol.2010.12.003","article-title":"Influenza virus assembly and budding","volume":"411","author":"Rossman","year":"2011","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2020.104780_bib106","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1016\/j.cell.2010.08.029","article-title":"Influenza virus M2 protein mediates ESCRT-independent membrane scission","volume":"142","author":"Rossman","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.antiviral.2020.104780_bib107","first-page":"5968","article-title":"Random mutagenesis analysis of the influenza A M2 proton channel reveals novel resistance mutants","volume":"57","author":"Santner","year":"2018","journal-title":"Cite This Biochem"},{"key":"10.1016\/j.antiviral.2020.104780_bib108","doi-asserted-by":"crossref","first-page":"5949","DOI":"10.1021\/acs.biochem.8b00721","article-title":"A robust proton flux (pHlux) assay for studying the function and inhibition of the influenza A M2 proton channel","volume":"57","author":"Santner","year":"2018","journal-title":"Biochemistry"},{"key":"10.1016\/j.antiviral.2020.104780_bib109","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/nature06531","article-title":"Structure and mechanism of the M2 proton channel of influenza A virus","volume":"451","author":"Schnell","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.antiviral.2020.104780_bib110","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0166-3542(97)00061-2","article-title":"How to overcome resistance of influenza A viruses against adamantane derivatives","volume":"37","author":"Scholtissek","year":"1998","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2020.104780_bib111","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1001\/jama.1969.03160070046011","article-title":"Amantadine in the treatment of Parkinson's disease","volume":"208","author":"Schwab","year":"1969","journal-title":"J. Am. Med. Assoc."},{"key":"10.1016\/j.antiviral.2020.104780_bib112","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1126\/science.1191750","article-title":"Insight into the mechanism of the influenza A proton channel from a structure in a lipid bilayer","volume":"330","author":"Sharma","year":"2010","journal-title":"Science (80-)"},{"key":"10.1016\/j.antiviral.2020.104780_bib113","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1016\/S0006-3495(96)79690-X","article-title":"Ion selectivity and activation of the M2ion channel of influenza virus","volume":"70","author":"Shimbo","year":"1996","journal-title":"Biophys. J."},{"key":"10.1016\/j.antiviral.2020.104780_bib114","doi-asserted-by":"crossref","first-page":"13029","DOI":"10.1128\/JVI.01430-14","article-title":"Stepwise priming by acidic pH and a high K concentration is required for efficient uncoating of influenza A virus cores after penetration","volume":"88","author":"Stauffer","year":"2014","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2020.104780_bib115","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1038\/nature06528","article-title":"Structural basis for the function and inhibition of an influenza virus proton channel","volume":"451","author":"Stouffer","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.antiviral.2020.104780_bib116","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1016\/j.bbamem.2013.06.029","article-title":"HIV-1 Vpu - an ion channel in search of a job","volume":"1838","author":"Strebel","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.antiviral.2020.104780_bib117","doi-asserted-by":"crossref","first-page":"3469","DOI":"10.1002\/j.1460-2075.1990.tb07555.x","article-title":"Specific structural alteration of the influenza haemagglutinin by amantadine","volume":"9","author":"Sugrue","year":"1990","journal-title":"EMBO J."},{"key":"10.1016\/j.antiviral.2020.104780_bib118","doi-asserted-by":"crossref","first-page":"10679","DOI":"10.1128\/JVI.01190-13","article-title":"Detection of proton movement directly across viral membranes to identify novel influenza virus M2 inhibitors","volume":"87","author":"Sulli","year":"2013","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2020.104780_bib119","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1000801","article-title":"The human polyoma JC virus agnoprotein acts as a viroporin","volume":"6","author":"Suzuki","year":"2010","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.antiviral.2020.104780_bib120","doi-asserted-by":"crossref","first-page":"14610","DOI":"10.1073\/pnas.2235620100","article-title":"Influenza virus hemagglutinin concentrates in lipid raft microdomains for efficient viral fusion","volume":"100","author":"Takeda","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.antiviral.2020.104780_bib121","doi-asserted-by":"crossref","first-page":"39880","DOI":"10.1074\/jbc.M206582200","article-title":"The gate of the influenza virus M 2 proton channel is formed by a single tryptophan residue","volume":"277","author":"Tang","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.antiviral.2020.104780_bib122","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/j.bmcl.2006.10.092","article-title":"Influence of an additional 2-amino substituent of the 1-aminoethyl pharmacophore group on the potency of rimantadine against influenza virus","volume":"17","author":"Tataridis","year":"2007","journal-title":"A. Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.antiviral.2020.104780_bib123","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.bbamem.2010.04.008","article-title":"Minimal art: or why small viral K+ channels are good tools for understanding basic structure and function relations","volume":"1808","author":"Thiel","year":"2011","journal-title":"Biochim. Biophys. Acta Biomembr."},{"key":"10.1016\/j.antiviral.2020.104780_bib124","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1002\/pro.2937","article-title":"Crystal structure of the drug-resistant S31N influenza M2 proton channel","volume":"25","author":"Thomaston","year":"2016","journal-title":"Protein Sci."},{"key":"10.1016\/j.antiviral.2020.104780_bib125","article-title":"X-ray crystal structures of the influenza M2 proton channel drug-resistant V27A mutant bound to a spiro-adamantyl amine inhibitor reveal the mechanism of adamantane resistance","author":"Thomaston","year":"2020","journal-title":"Biochemistry acs.biochem.9b00971"},{"key":"10.1016\/j.antiviral.2020.104780_bib126","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1002\/pro.2186","article-title":"Detection of drug-induced conformational change of a transmembrane protein in lipid bilayers using site-directed spin labeling","volume":"22","author":"Thomaston","year":"2013","journal-title":"Protein Sci."},{"key":"10.1016\/j.antiviral.2020.104780_bib127","doi-asserted-by":"crossref","first-page":"15219","DOI":"10.1021\/jacs.8b06741","article-title":"Inhibitors of the M2 proton channel engage and disrupt transmembrane networks of hydrogen-bonded waters","volume":"140","author":"Thomaston","year":"2018","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.antiviral.2020.104780_bib128","doi-asserted-by":"crossref","first-page":"13357","DOI":"10.1073\/pnas.1705624114","article-title":"XFEL structures of the influenza M2 proton channel: room temperature water networks and insights into proton conduction","volume":"114","author":"Thomaston","year":"2017","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.antiviral.2020.104780_bib129","doi-asserted-by":"crossref","first-page":"11481","DOI":"10.1021\/jacs.9b02196","article-title":"X-Ray crystal structure of the influenza A M2 proton channel S31N mutant in two conformational states: an open and shut case","volume":"141","author":"Thomaston","year":"2019","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.antiviral.2020.104780_bib130","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0121099","article-title":"Screening of the pan-african natural product library identifies ixoratannin A-2 and boldine as novel HIV-1 inhibitors","volume":"10","author":"Tietjen","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.antiviral.2020.104780_bib131","doi-asserted-by":"crossref","first-page":"654","DOI":"10.3390\/cells8070654","article-title":"Viroporins in the influenza virus","volume":"8","author":"To","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.antiviral.2020.104780_bib132","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.tibs.2008.10.009","article-title":"Do viral proteins possess unique biophysical features?","volume":"34","author":"Tokuriki","year":"2009","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.antiviral.2020.104780_bib133","doi-asserted-by":"crossref","first-page":"4246","DOI":"10.1128\/jvi.70.7.4246-4252.1996","article-title":"Characterization of inhibition of M2 ion channel activity by BL-1743, an inhibitor of influenza A virus","volume":"70","author":"Tu","year":"1996","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2020.104780_bib134","series-title":"Design and Synthesis of Depeptidized 5088\u20135091","author":"Venkatraman","year":"2005"},{"key":"10.1016\/j.antiviral.2020.104780_bib135","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1016\/S0006-3495(95)80003-2","article-title":"Activation of the M2 ion channel of influenza virus: a role for the transmembrane domain histidine residue","volume":"69","author":"Wang","year":"1995","journal-title":"Biophys. J."},{"key":"10.1016\/j.antiviral.2020.104780_bib136","doi-asserted-by":"crossref","first-page":"5585","DOI":"10.1128\/jvi.67.9.5585-5594.1993","article-title":"Ion channel activity of influenza A virus M2 protein: characterization of the amantadine block","volume":"67","author":"Wang","year":"1993","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2020.104780_bib137","doi-asserted-by":"crossref","first-page":"8066","DOI":"10.1021\/ja900063s","article-title":"Discovery of spiro-piperidine inhibitors and their modulation of the dynamics of the M2 proton channel from influenza A virus","volume":"131","author":"Wang","year":"2009","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.antiviral.2020.104780_bib138","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1002\/bip.22623","article-title":"Recent progress in designing inhibitors that target the drug-resistant M2 proton channels from the influenza a viruses","volume":"104","author":"Wang","year":"2015","journal-title":"Biopolymers"},{"key":"10.1016\/j.antiviral.2020.104780_bib139","doi-asserted-by":"crossref","first-page":"12834","DOI":"10.1021\/ja204969m","article-title":"Molecular dynamics simulation directed rational design of inhibitors targeting drug-resistant mutants of influenza A virus M2","volume":"133","author":"Wang","year":"2011","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.antiviral.2020.104780_bib140","doi-asserted-by":"crossref","first-page":"13844","DOI":"10.1021\/ja2050666","article-title":"Exploring organosilane amines as potent inhibitors and structural probes of influenza A virus M2 proton channel","volume":"133","author":"Wang","year":"2011","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.antiviral.2020.104780_bib141","doi-asserted-by":"crossref","DOI":"10.1016\/j.sbi.2010.12.002","article-title":"Structural and dynamic mechanisms for the function and inhibition of the M2 proton channel from influenza A virus","author":"Wang","year":"2011","journal-title":"Curr. Opin. Struct. Biol."},{"key":"10.1016\/j.antiviral.2020.104780_bib142","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1073\/pnas.1216526110","article-title":"Structure and inhibition of the drug-resistant S31N mutant of the M2 ion channel of influenza A virus","volume":"110","author":"Wang","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.antiviral.2020.104780_bib143","doi-asserted-by":"crossref","first-page":"2804","DOI":"10.1021\/jm301538e","article-title":"Discovery of novel dual inhibitors of the wild-type and the most prevalent drug-resistant mutant, S31N, of the M2 proton channel from influenza A virus","volume":"56","author":"Wang","year":"2013","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.antiviral.2020.104780_bib144","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1021\/acs.jmedchem.7b01536","article-title":"In vitro pharmacokinetic optimizations of AM2-S31N channel blockers led to the discovery of slow-binding inhibitors with potent antiviral activity against drug-resistant influenza A viruses","volume":"61","author":"Wang","year":"2018","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.antiviral.2020.104780_bib145","doi-asserted-by":"crossref","first-page":"11667","DOI":"10.1021\/jacs.9b05136","article-title":"Proton induced conformational and hydration dynamics in the influenza A M2 channel HHS public access","volume":"141","author":"Watkins","year":"2019","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.antiviral.2020.104780_bib146","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1056\/NEJM196909112811102","article-title":"Therapeutic efficacy of amantadine HCl and rimantadine HCl in naturally occurring influenza A2 respiratory illness in man","volume":"281","author":"Wingfield","year":"1969","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.antiviral.2020.104780_bib147","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1021\/jacs.5b13129","article-title":"Differential binding of rimantadine enantiomers to influenza A M2 proton channel","volume":"138","author":"Wright","year":"2016","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.antiviral.2020.104780_bib148","doi-asserted-by":"crossref","first-page":"17987","DOI":"10.1021\/ja508461m","article-title":"Flipping in the pore: discovery of dual inhibitors that bind in different orientations to the wild-type versus the amantadine-resistant s31n mutant of the influenza a virus m2 proton channel","volume":"136","author":"Wu","year":"2014","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.antiviral.2020.104780_bib149","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.antiviral.2012.09.001","article-title":"Design and synthesis of pinanamine derivatives as anti-influenza A M2 ion channel inhibitors","volume":"96","author":"Zhao","year":"2012","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2020.104780_bib150","doi-asserted-by":"crossref","DOI":"10.1002\/pro.2232","article-title":"Modeling the membrane environment has implications for membrane protein structure and function: influenza A M2 protein","author":"Zhou","year":"2013","journal-title":"Protein Sci."}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354219305820?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354219305820?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T12:31:49Z","timestamp":1759062709000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166354219305820"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6]]},"references-count":152,"alternative-id":["S0166354219305820"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2020.104780","relation":{},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2020,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Put a cork in it: Plugging the M2 viral ion channel to sink influenza","name":"articletitle","label":"Article Title"},{"value":"Antiviral Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.antiviral.2020.104780","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"104780"}}